RecruitingNot applicableFemale onlyBreast cancerHormone receptor positive (HR+)Metastatic / advanced
NCT07179809ClinicalTrials.gov ↗
The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
1 clinical trials involving this therapy/drug
This is not medical advice - consult your oncologist
Descriptions are automatically translated with AI assistance. Always verify details in the original on ClinicalTrials.gov and consult your treating physician.
The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.
We use Google Analytics to understand how you use our tools and to improve them. We don't collect health data and we don't show ads. You can decline - the site will work exactly the same. Privacy policy